I'm sorry to hear that, and I didn't mean any disrespect with my comment.

I just think it would be prudent to temper expectations with this very deadly disease. Tripling the survival rate is wonderful, but from a statistical point of view the odds of survival increase by just 8% at the 5 year mark. Everything helps of course.

One of my biggest concerns is how expensive this treatment will cost and what insurance may cover it. From the article, it seems to be a very involved, customized, process. Many insurances may not elect to cover it if their cost/benefit analysis formulas show it's not mathematically viable for them.

I wouldn't say groundbreaking, but it's promising. It increases survival rate from 5% to something like 13% past 5 years. I think groundbreaking would be something like 20%, 30% or 40% or more